Showing results (111-120 of 587) with videos related to
Sort By:
Pageof 59
Psychological Medicine|February 20, 2018
Distinct risk factors for obsessive and compulsive symptoms in chronic schizophreniaEmilio Fernandez-Egea, Yulia Worbe, Miguel Bernardo, et al.Neuropharmacology|August 14, 2012
The mGlu₅ positive allosteric modulator LSN2463359 differentially modulates motor, instrumental and cognitive effects of NMDA receptor antagonists in the ratFrancois Gastambide, Gary Gilmour, Trevor W Robbins, et al.Psychiatry Research|August 28, 2010
Differences in self-reported decision-making styles in stimulant-dependent and opiate-dependent individualsHadas Gorodetzky, Barbara J Sahakian, Trevor W Robbins, et al.The European Journal of Neuroscience|April 21, 2015
Ramping single unit activity in the medial prefrontal cortex and ventral striatum reflects the onset of waiting but not imminent impulsive actionsNicholas A Donnelly, Ole Paulsen, Trevor W Robbins, et al.Neural Networks : the Official Journal of the International Neural Network Society|October 10, 2002
Local analysis of behaviour in the adjusting-delay task for assessing choice of delayed reinforcementRudolf N Cardinal, Nathaniel Daw, Trevor W Robbins, et al.Frontiers in Psychology|January 24, 2020
A Mobile Phone App for the Generation and Characterization of Motor HabitsPaula Banca, Daniel McNamee, Thomas Piercy, et al.CNS Spectrums|October 21, 2020
Obsessive-compulsive disorder-contamination fears, features, and treatment: novel smartphone therapies in light of global mental health and pandemics (COVID-19)Baland Jalal, Samuel R Chamberlain, Trevor W Robbins, et al.Neuroscience and Biobehavioral Reviews|November 22, 2016
A review of molecular genetic studies of neurocognitive deficits in schizophreniaGwyneth Zai, Trevor W Robbins, Barbara J Sahakian, et al.Translational Psychiatry|November 16, 2018
Continuous performance test impairment in a 22q11.2 microdeletion mouse model: improvement by amphetamineSimon R O Nilsson, Christopher J Heath, Samir Takillah, et al.Neuropsychologia|July 10, 2003
L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's diseaseRoshan Cools, Roger A Barker, Barbara J Sahakian, et al.Pageof 59